CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital	Accumulated other comprehensive income (loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2020	$ 384,520	$ 13	$ 775,417		$ (390,910)
Beginning balance (in shares) at Dec. 31, 2020		127,123,954
Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)		14,270
Issuance of common stock under equity incentive plans related to exercise of options	742		742
Issuance of common stock under equity incentive plans related to exercise of options (in shares)		186,892
Reclassification of private placement warrants from equity to other long-term liabilities	(305)		(305)
Equity-based compensation expense	6,060		6,060
Net loss	(50,981)				(50,981)
Ending balance at Mar. 31, 2021	340,036	$ 13	781,914		(441,891)
Ending balance (in shares) at Mar. 31, 2021		127,325,116
Beginning balance at Dec. 31, 2020	384,520	$ 13	775,417		(390,910)
Beginning balance (in shares) at Dec. 31, 2020		127,123,954
Net loss	(104,220)
Ending balance at Jun. 30, 2021	293,887	$ 13	789,004		(495,130)
Ending balance (in shares) at Jun. 30, 2021		127,584,659
Beginning balance at Mar. 31, 2021	340,036	$ 13	781,914		(441,891)
Beginning balance (in shares) at Mar. 31, 2021		127,325,116
Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)		14,270
Issuance of common stock under equity incentive plans related to exercise of options	1,394		1,394
Issuance of common stock under equity incentive plans related to exercise of options (in shares)		204,684
Issuance of common stock under equity incentive plans related to ESPP	435		435
Issuance of common stock under equity incentive plans related to ESPP (in shares)		40,589
Equity-based compensation expense	5,261		5,261
Net loss	(53,239)				(53,239)
Ending balance at Jun. 30, 2021	293,887	$ 13	789,004		(495,130)
Ending balance (in shares) at Jun. 30, 2021		127,584,659
Beginning balance at Dec. 31, 2021	578,729	$ 15	1,195,944	$ (986)	(616,244)
Beginning balance (in shares) at Dec. 31, 2021		147,719,523
Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)		14,270
Issuance of common stock under equity incentive plans related to exercise of options	2,854		2,854
Issuance of common stock under equity incentive plans related to exercise of options (in shares)		449,005
Equity-based compensation expense	8,558		8,558
Other comprehensive income (loss)	(348)			(348)
Net loss	(68,294)				(68,294)
Ending balance at Mar. 31, 2022	521,499	$ 15	1,207,356	(1,334)	(684,538)
Ending balance (in shares) at Mar. 31, 2022		148,182,798
Beginning balance at Dec. 31, 2021	578,729	$ 15	1,195,944	(986)	(616,244)
Beginning balance (in shares) at Dec. 31, 2021		147,719,523
Other comprehensive income (loss)	8,974
Net loss	(158,765)
Ending balance at Jun. 30, 2022	452,814	$ 15	1,219,820	7,988	(775,009)
Ending balance (in shares) at Jun. 30, 2022		148,395,282
Beginning balance at Mar. 31, 2022	521,499	$ 15	1,207,356	(1,334)	(684,538)
Beginning balance (in shares) at Mar. 31, 2022		148,182,798
Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)		14,270
Issuance of common stock under equity incentive plans related to exercise of options	1,471		1,471
Issuance of common stock under equity incentive plans related to exercise of options (in shares)		160,623
Issuance of common stock under equity incentive plans related to ESPP	845		845
Issuance of common stock under equity incentive plans related to ESPP (in shares)		37,591
Equity-based compensation expense	10,148		10,148
Other comprehensive income (loss)	9,322			9,322
Net loss	(90,471)				(90,471)
Ending balance at Jun. 30, 2022	$ 452,814	$ 15	$ 1,219,820	$ 7,988	$ (775,009)
Ending balance (in shares) at Jun. 30, 2022		148,395,282